Literature DB >> 9875240

Identification of a binding site on Hsc70 for the immunosuppressant 15-deoxyspergualin.

S G Nadler1, D D Dischino, A R Malacko, J S Cleaveland, S M Fujihara, H Marquardt.   

Abstract

Hsc70, the constitutive form of the heat shock protein 70 family of proteins, is involved in a number of biological activities which include protein folding and molecular chaperoning. Previously, we had shown that the immunosuppressant 15-deoxyspergualin (DSG) specifically interacted with Hsc70, as well as the Hsp90 family of proteins. Although the exact binding site on Hsc70 for protein substrates is unknown, a recent study shows that the extreme C-terminal four amino acids 647EEVD650 play a role in regulating AT-Pase activity, substrate binding, and interaction with HDJ-1. These four amino acids are also found at the C-terminus of Hsp90 and may be involved in similar functions. In this study, we show that DSG binds specifically to this EEVD regulatory domain. Binding of DSG to Hsc70 did not affect its ability to bind peptides. These results suggest that in addition to the ATP binding domain, there are two additional substrate binding domains on Hsc70. DSG should provide a tool for understanding the role of the EEVD motif in biological processes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875240     DOI: 10.1006/bbrc.1998.9775

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  The human HSP70 family of chaperones: where do we stand?

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

Review 2.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

Review 3.  Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.

Authors:  Amanda K Davis; William B Pratt; Andrew P Lieberman; Yoichi Osawa
Journal:  Cell Mol Life Sci       Date:  2019-09-24       Impact factor: 9.261

4.  Design and synthesis of 15-deoxyspergualin-biotin conjugates as novel binding probes for target protein screening.

Authors:  Masahiko Morioka; Kuniki Kato; Kazuo Umezawa
Journal:  J Antibiot (Tokyo)       Date:  2016-03-23       Impact factor: 2.649

5.  Allosteric drugs: the interaction of antitumor compound MKT-077 with human Hsp70 chaperones.

Authors:  Aikaterini Rousaki; Yoshinari Miyata; Umesh K Jinwal; Chad A Dickey; Jason E Gestwicki; Erik R P Zuiderweg
Journal:  J Mol Biol       Date:  2011-06-25       Impact factor: 5.469

6.  15-deoxyspergualin inhibits eukaryotic protein synthesis through eIF2alpha phosphorylation.

Authors:  T N C Ramya; Namita Surolia; Avadhesha Surolia
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

Review 7.  Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.

Authors:  David A Jacobsohn; Georgia B Vogelsang
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Identification and characterization of a 66-68-kDa protein as a methotrexate-binding protein in murine leukemia L1210 cells.

Authors:  Tuoen Liu; Allison Dean; Saint Ashwini; Peter P Sheridan; Alok Bhushan; James C K Lai; Shousong Cao; Christopher K Daniels
Journal:  Cell Stress Chaperones       Date:  2012-10-23       Impact factor: 3.667

9.  Pyrimidinone-peptoid hybrid molecules with distinct effects on molecular chaperone function and cell proliferation.

Authors:  Christine M Wright; Raj J Chovatiya; Nora E Jameson; David M Turner; Guangyu Zhu; Stefan Werner; Donna M Huryn; James M Pipas; Billy W Day; Peter Wipf; Jeffrey L Brodsky
Journal:  Bioorg Med Chem       Date:  2007-12-14       Impact factor: 3.641

10.  Polyamine compound deoxyspergualin inhibits heat shock protein-induced activation of immature dendritic cells.

Authors:  Atsushi Sugawara; Toshihiko Torigoe; Yasuaki Tamura; Kenjiro Kamiguchi; Kyuichi Nemoto; Hiroshi Oguro; Noriyuki Sato
Journal:  Cell Stress Chaperones       Date:  2008-08-07       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.